# Schwabe North America, Inc. – FDA Inspection, Aug 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/2a20f4c9-bff6-4252-8981-26339d01753b
Source feed: FDA_Inspections

> FDA inspection 1271627 of Schwabe North America, Inc., August 28, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271627
- Company Name: Schwabe North America, Inc.
- Inspection Date: 2025-08-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1253920 - 2025-02-19](https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/9380f389-6150-48c3-933d-7ff259060e60)
- FDA Inspection 1157191 - 2021-09-21
- FDA Inspection 1105193 - 2019-08-20
- FDA Inspection 993338 - 2016-11-10
- FDA Inspection 991787 - 2016-10-28

## Related Officers

- [Azeezat M. Lawal](https://www.keypedia.com/people/azeezat-m-lawal/6068345c-a8c8-438e-9b59-f7fc35370a59)
- [Investigator](https://www.keypedia.com/people/ogechi-c-nna/59452184-8197-4ba6-bf1d-78a7e003ef2c)

Company: https://www.keypedia.com/companies/schwabe-north-america-inc/ac030767-09e8-4377-99ee-7360176e40ed

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
